10.29
price up icon1.18%   0.12
after-market Handel nachbörslich: 10.01 -0.28 -2.72%
loading
Schlusskurs vom Vortag:
$10.17
Offen:
$10.09
24-Stunden-Volumen:
88,923
Relative Volume:
0.57
Marktkapitalisierung:
$508.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-76.41M
KGV:
-5.145
EPS:
-2
Netto-Cashflow:
$-64.56M
1W Leistung:
-3.92%
1M Leistung:
+18.00%
6M Leistung:
+30.42%
1J Leistung:
-14.11%
1-Tages-Spanne:
Value
$10.04
$10.39
1-Wochen-Bereich:
Value
$10.04
$10.73
52-Wochen-Spanne:
Value
$5.99
$12.38

Aura Biosciences Inc Stock (AURA) Company Profile

Name
Firmenname
Aura Biosciences Inc
Name
Telefon
(617)500-8864
Name
Adresse
80 GUEST STREET, BOSTON
Name
Mitarbeiter
89
Name
Twitter
Name
Nächster Verdiensttermin
2024-08-07
Name
Neueste SEC-Einreichungen
Name
AURA's Discussions on Twitter

Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-07-27 Eingeleitet Scotiabank Sector Outperform
2023-04-17 Fortgesetzt BTIG Research Buy
2022-07-19 Eingeleitet JMP Securities Mkt Outperform

Aura Biosciences Inc Aktie (AURA) Neueste Nachrichten

pulisher
Nov 01, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Update - Defense World

Nov 01, 2024
pulisher
Oct 31, 2024

One Aura Biosciences Insider Raised Stake By 232% In Previous Year - Yahoo Finance

Oct 31, 2024
pulisher
Oct 30, 2024

Short Interest in Aura Biosciences, Inc. (NASDAQ:AURA) Decreases By 8.7% - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) Insider Sells $98,808.00 in Stock - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

Aura Biosciences VP sells shares worth $5,938 By Investing.com - Investing.com Australia

Oct 29, 2024
pulisher
Oct 29, 2024

Aura Biosciences CEO Elisabet de los Pinos sells $98,787 in stock By Investing.com - Investing.com South Africa

Oct 29, 2024
pulisher
Oct 29, 2024

Aura Biosciences CEO Elisabet de los Pinos sells $98,787 in stock - Investing.com

Oct 29, 2024
pulisher
Oct 29, 2024

Aura Biosciences VP sells shares worth $5,938 - Investing.com

Oct 29, 2024
pulisher
Oct 23, 2024

Don't Ignore The Insider Selling In Aura Biosciences - Simply Wall St

Oct 23, 2024
pulisher
Oct 23, 2024

Aura Biosciences (NASDAQ:AURA) Stock Price Down 4.9% After Insider Selling - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

Aura Biosciences CFO Julie Feder sells shares worth $302,361 - Investing.com India

Oct 22, 2024
pulisher
Oct 22, 2024

Aura Biosciences (NASDAQ:AURA) Trading Down 4.9% on Insider Selling - MarketBeat

Oct 22, 2024
pulisher
Oct 21, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) CFO Sells $302,325.93 in Stock - MarketBeat

Oct 21, 2024
pulisher
Oct 21, 2024

Aura Biosciences: 2 Positive Bel-Sar Data Releases Brings Shareholder Value - Seeking Alpha

Oct 21, 2024
pulisher
Oct 21, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) Receives $23.00 Average Price Target from Analysts - Defense World

Oct 21, 2024
pulisher
Oct 20, 2024

Long Term Trading Analysis for (AURA) - Stock Traders Daily

Oct 20, 2024
pulisher
Oct 20, 2024

Aura Biosciences (NASDAQ:AURA) PT Raised to $22.00 at HC Wainwright - Defense World

Oct 20, 2024
pulisher
Oct 19, 2024

Aura Biosciences stock hits 52-week high at $12.38 By Investing.com - Investing.com Australia

Oct 19, 2024
pulisher
Oct 19, 2024

Aura Biosciences CEO sells $300,838 in stock By Investing.com - Investing.com Australia

Oct 19, 2024
pulisher
Oct 19, 2024

Aura Biosciences reports promising early trial results - Investing.com India

Oct 19, 2024
pulisher
Oct 18, 2024

Insider Selling: Aura Biosciences, Inc. (NASDAQ:AURA) Insider Sells 24,992 Shares of Stock - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences CEO sells $300,838 in stock - Investing.com

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences' Shares Touch 52-Week High on Positive Cancer Drug Data - MarketWatch

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences (NASDAQ:AURA) Hits New 12-Month High After Analyst Upgrade - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences stock hits 52-week high at $12.38 - Investing.com

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences stock maintains Buy rating on promising trial results By Investing.com - Investing.com Canada

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences' Bladder Cancer Candidate Demonstrates Tumor Shrinkage In Patients With High-Grade Disease - Benzinga

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences (NASDAQ:AURA) Price Target Increased to $23.00 by Analysts at Scotiabank - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences stock price target up 5%, H.C. Wainwright rates Buy after virtual oncology event - Investing.com Canada

Oct 18, 2024
pulisher
Oct 18, 2024

Aura Biosciences Shares Surge After-Hour On Positive Clinical Trial Results - Stocks Telegraph

Oct 18, 2024
pulisher
Oct 17, 2024

Multiple Clinical Complete Responses Demonstrated Following - GlobeNewswire

Oct 17, 2024
pulisher
Oct 17, 2024

Aura Biosciences Reports Positive Phase 1 Trial Results - TipRanks

Oct 17, 2024
pulisher
Oct 17, 2024

Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial - The Manila Times

Oct 17, 2024
pulisher
Oct 17, 2024

Aura Biosciences reports promising early trial results By Investing.com - Investing.com UK

Oct 17, 2024
pulisher
Oct 16, 2024

Mark Plavsic Sells 7,383 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) Stock - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Aura Biosciences CTO Mark Plavsic sells $72,722 in shares By Investing.com - Investing.com South Africa

Oct 16, 2024
pulisher
Oct 16, 2024

Aura Biosciences CTO Mark Plavsic sells $72,722 in shares - Investing.com India

Oct 16, 2024
pulisher
Oct 16, 2024

With 58% ownership in Aura Biosciences, Inc. (NASDAQ:AURA), institutional investors have a lot riding on the business - Simply Wall St

Oct 16, 2024
pulisher
Oct 15, 2024

3 Small-Cap Stocks Ready to Deliver Significant Growth - Benzinga

Oct 15, 2024
pulisher
Oct 14, 2024

Short Interest in Aura Biosciences, Inc. (NASDAQ:AURA) Decreases By 12.2% - MarketBeat

Oct 14, 2024
pulisher
Oct 09, 2024

(AURA) Proactive Strategies - Stock Traders Daily

Oct 09, 2024
pulisher
Oct 04, 2024

Regency Capital Management Inc. DE Sells 97,744 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

Aura Biosciences, Inc. (NASDAQ:AURA) is a favorite amongst institutional investors who own 58% - Yahoo Finance

Oct 04, 2024
pulisher
Sep 28, 2024

Where are the Opportunities in (AURA) - Stock Traders Daily

Sep 28, 2024
pulisher
Sep 28, 2024

Ensign Peak Advisors Inc Sells 105,316 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Aura Biosciences names interim CFO as Julie Feder departs By Investing.com - Investing.com Australia

Sep 27, 2024
pulisher
Sep 27, 2024

Aura Biosciences names interim CFO as Julie Feder departs - Investing.com

Sep 27, 2024
pulisher
Sep 27, 2024

Wall Street SWOT: Aura Biosciences stock shows promise amid cancer treatment trials - Investing.com

Sep 27, 2024

Finanzdaten der Aura Biosciences Inc-Aktie (AURA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):